In Vivo Actions of Peroxisome Proliferator-Activated Receptors Glycemic control, insulin sensitivity, and insulin secretion

被引：81
作者：
Eldor, Roy [1 ]
DeFronzo, Ralph A. [1 ]
Abdul-Ghani, Muhammad [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA
来源：
DIABETES CARE | 2013年 / 36卷
关键词：
TYPE-2; DIABETES-MELLITUS; PLACEBO-CONTROLLED TRIAL; BETA-CELL FUNCTION; FREE FATTY-ACIDS; HOMEOSTASIS MODEL ASSESSMENT; PIOGLITAZONE CLINICAL-TRIAL; NUCLEAR HORMONE-RECEPTORS; BODY-MASS INDEX; PPAR-GAMMA; SKELETAL-MUSCLE;
D O I：
10.2337/dcS13-2003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S162 / S174
页数：13
相关论文
共 50 条
[21]   Peroxisome proliferator-activated receptors: a therapeutic target in COPD? [J].
Remels, A. H. ;
Gosker, H. R. ;
Schrauwen, P. ;
Langen, R. C. ;
Schols, A. M. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (03) :502-508
[22]   The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer [J].
Psilopatis, Iason ;
Vrettou, Kleio ;
Troungos, Constantinos ;
Theocharis, Stamatios .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (11)
[23]   Peroxisome Proliferator-Activated Receptors in Female Reproduction and Fertility [J].
Vitti, Maurizio ;
Di Emidio, Giovanna ;
Di Carlo, Michela ;
Carta, Gaspare ;
Antonosante, Andrea ;
Artini, Paolo Giovanni ;
Cimini, Annamaria ;
Tatone, Carla ;
Benedetti, Elisabetta .
PPAR RESEARCH, 2016, 2016
[24]   Peroxisome Proliferator-Activated Receptors of Trophoblast Cells in Miscarriage [J].
Alexandrova, N. V. ;
Dubova, E. A. ;
Baev, O. R. ;
Shchegolev, A. I. ;
Sukhikh, G. T. .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 152 (06) :768-771
[25]   Peroxisome proliferator-activated receptors-γ and hypertension: Lessons of the history of researches [J].
Rasin, M. S. .
TERAPEVTICHESKII ARKHIV, 2013, 85 (09) :118-123
[26]   Comparative Evaluation of Gemcabene and Peroxisome Proliferator-Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease [J].
Bisgaier, Charles L. ;
Oniciu, Daniela C. ;
Srivastava, Rai Ajit K. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2018, 72 (01) :3-10
[27]   Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor γ and thiazolidinedione oral antidiabetic drugs [J].
Schinner, S. ;
Kraetzer, R. ;
Baun, D. ;
Dickel, C. ;
Blume, R. ;
Oetjen, E. .
BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (05) :736-745
[28]   Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects [J].
Cariou, Bertrand ;
Hanf, Remy ;
Lambert-Porcheron, Stephanie ;
Zair, Yassine ;
Sauvinet, Valerie ;
Noel, Benoit ;
Flet, Laurent ;
Vidal, Hubert ;
Staels, Bart ;
Laville, Martine .
DIABETES CARE, 2013, 36 (10) :2923-2930
[29]   Novel Thiazolidinedione and Rhodanine Derivatives Regulate Glucose Metabolism, Improve Insulin Sensitivity, and Activate the Peroxisome Proliferator-Activated γ Receptor [J].
Al Neyadi, Shaikha S. ;
Adem, Abdu ;
Amir, Naheed ;
Ghattas, Mohammad A. ;
Abdou, Ibrahim M. ;
Salem, Alaa A. .
ACS OMEGA, 2024, 9 (05) :5463-5484
[30]   Peroxisome proliferator-activated receptors in cardiacenergy metabolism and cardiovascular disease [J].
Ajith, Thekkuttuparambil Ananthanarayanan ;
Jayakumar, Thankamani Gopinathan .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2016, 43 (07) :649-658
12345